Abstract
United Arab Emirates Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
Summary
”United Arab Emirates Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the United Arab Emirates Drug Delivery Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
• Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Infusion Systems, Inhalation Systems, Metered Dose Inhaler Devices and Needle Free Injections.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the five market categories.
• Global corporate-level profiles of key companies operating within the United Arab Emirates Drug Delivery Devicesmarket.
• Key players covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Fresenius Kabi AG, Medtronic, Inc., Sunovion and others.
Reasons to buy
• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the United Arab Emirates Drug Delivery Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Drug Delivery Devices In United Arab Emirates 10
3.1 Drug Delivery Devices, United Arab Emirates, Overall Revenue ($m), 2003-2017 10
3.2 Drug Delivery Devices, United Arab Emirates, Category Volume (Units), 2003-2017 16
3.3 Drug Delivery Devices, United Arab Emirates, Company Share (2009-2010) 21
4 Central Venous Catheters In United Arab Emirates 23
4.1 Central Venous Catheters Overall Revenue (2003-2017) 23
4.2 Central Venous Catheters Overall Volume (2003-2017) 27
4.3 Central Venous Catheters Average Price (2003-2017) 31
4.4 Central Venous Catheters Distribution Share (2009-2010) 32
4.5 Central Venous Catheters, United Arab Emirates, Company Share (2009-2010) 33
5 Infusion Systems In United Arab Emirates 35
5.1 Infusion Systems Overall Revenue (2003-2017) 35
5.1.1 Syringe Pumps Revenue (2003-2017) 39
5.1.2 Ambulatory Infusion Pumps Revenue (2003-2017) 43
5.2 Infusion Systems Overall Volume (2003-2017) 47
5.2.1 Syringe Pumps Volume (2003-2017) 51
5.2.2 Ambulatory Infusion Pumps Volume (2003-2017) 55
5.3 Infusion Systems Average Price (2003-2017) 59
5.4 Infusion Systems Distribution Share (2009-2010) 60
5.5 Infusion Systems, United Arab Emirates, Company Share (2009-2010) 61
6 Metered Dose Inhaler Devices In United Arab Emirates 63
6.1 Metered Dose Inhaler Devices Overall Revenue (2003-2017) 63
6.2 Metered Dose Inhaler Devices Overall Volume (2003-2017) 65
6.3 Metered Dose Inhaler Devices Average Price (2003-2017) 67
6.4 Metered Dose Inhaler Devices Distribution Share (2009-2010) 68
6.5 Metered Dose Inhaler Devices, United Arab Emirates, Company Share (2009-2010) 69
7 Needle Free Injections In United Arab Emirates 71
7.1 Needle Free Injections Overall Revenue (2003-2017) 71
7.2 Needle Free Injections Overall Volume (2003-2017) 73
7.3 Needle Free Injections Average Price (2003-2017) 75
7.4 Needle Free Injections Distribution Share (2009-2010) 76
7.5 Needle Free Injections, United Arab Emirates, Company Share (2009-2010) 77
8 Overview of Key Companies in United Arab Emirates Drug Delivery Devices Market 78
8.1 GlaxoSmithKline plc 78
8.1.1 Company Overview 78
8.2 AstraZeneca PLC 78
8.2.1 Company Overview 78
8.3 Boehringer Ingelheim GmbH 78
8.3.1 Company Overview 78
8.4 Medtronic, Inc. 79
8.4.1 Company Overview 79
8.5 Fresenius Kabi AG 79
8.5.1 Company Overview 79
8.6 Hospira, Inc. 79
8.6.1 Company Overview 79
8.7 B. Braun Melsungen AG 80
8.7.1 Company Overview 80
8.8 Baxter International Inc. 80
8.8.1 Company Overview 80
8.9 Smiths Medical 80
8.9.1 Company Overview 80
8.10 Terumo Corporation 81
8.10.1 Company Overview 81
8.11 CareFusion Corporation 81
8.11.1 Company Overview 81
8.12 3M Health Care 81
8.12.1 Company Overview 81
8.13 Arcomed A.G. Medical Systems 82
8.13.1 Company Overview 82
8.14 Consort Medical plc 82
8.14.1 Company Overview 82
8.15 JMS CO., LTD. 82
8.15.1 Company Overview 82
8.16 INJEX - Equidyne Systems 83
8.16.1 Company Overview 83
8.17 Bioject Medical Technologies Inc. 83
8.17.1 Company Overview 83
9 Appendix 84
9.1 Global Markets Direct Research Methodology 84
9.2 Definitions of Markets Covered in the Report 85
9.2.1 Drug Delivery Devices 85
9.3 Secondary Research 88
9.4 Primary Research 88
9.5 Models 89
9.6 Forecasts 89
9.7 Expert Panel Validation 89
9.8 Currency Conversion 90
9.9 Contact Us 90
9.10 Disclaimer 90
List of Tables
1.1 List of Tables
Table 1: Drug Delivery Devices, United Arab Emirates, Overall Revenue ($m), 2003-2017 11
Table 2: Drug Delivery Devices, United Arab Emirates, Overall Revenue ($m), Historic, 2003-2010 13
Table 3: Drug Delivery Devices, United Arab Emirates, Overall Revenue ($m), Forecast, 2010-2017 15
Table 4: Drug Delivery Devices, United Arab Emirates, Category Volume (Units), 2003-2017 16
Table 5: Drug Delivery Devices, United Arab Emirates, Category Volume (Units), Historic, 2003-2010 18
Table 6: Drug Delivery Devices, United Arab Emirates, Category Volume (Units), Forecast, 2010-2017 20
Table 7: Drug Delivery Devices, United Arab Emirates, Company Share by Revenue ($m), 2009-2010 22
Table 8: Central Venous Catheters, United Arab Emirates, Revenue ($m) by Segment, Historic, 2003-2010 24
Table 9: Central Venous Catheters, United Arab Emirates, Revenue ($m) by Segment, Forecast, 2010-2017 26
Table 10: Central Venous Catheters, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010 28
Table 11: Central Venous Catheters, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017 30
Table 12: Central Venous Catheters, United Arab Emirates, Average Price ($), Historic, 2003-2010 31
Table 13: Central Venous Catheters, United Arab Emirates, Average Price ($), Forecast, 2010-2017 31
Table 14: Central Venous Catheters, United Arab Emirates, Distribution Share by Revenue ($m), 2009-2010 32
Table 15: Central Venous Catheters, United Arab Emirates, Company Share by Revenue ($m), 2009-2010 34
Table 16: Infusion Systems, United Arab Emirates, Revenue ($m) by Segment, Historic, 2003-2010 36
Table 17: Infusion Systems, United Arab Emirates, Revenue ($m) by Segment, Forecast, 2010-2017 38
Table 18: Syringe Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Historic, 2003-2010 40
Table 19: Syringe Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 42
Table 20: Ambulatory Infusion Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Historic, 2003-2010 44
Table 21: Ambulatory Infusion Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 46
Table 22: Infusion Systems, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010 48
Table 23: Infusion Systems, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017 50
Table 24: Syringe Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2003-2010 52
Table 25: Syringe Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2010-2017 54
Table 26: Ambulatory Infusion Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2003-2010 56
Table 27: Ambulatory Infusion Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2010-2017 58
Table 28: Infusion Systems, United Arab Emirates, Average Price ($), Historic, 2003-2010 59
Table 29: Infusion Systems, United Arab Emirates, Average Price ($), Forecast, 2010-2017 59
Table 30: Infusion Systems, United Arab Emirates, Distribution Share by Revenue ($m), 2009-2010 60
Table 31: Infusion Systems, United Arab Emirates, Company Share by Revenue ($m), 2009-2010 62
Table 32: Metered Dose Inhaler Devices, United Arab Emirates, Revenue ($m), Historic, 2003-2010 63
Table 33: Metered Dose Inhaler Devices, United Arab Emirates, Revenue ($m), Forecast, 2010-2017 64
Table 34: Metered Dose Inhaler Devices, United Arab Emirates, Volume (Units), Historic, 2003-2010 65
Table 35: Metered Dose Inhaler Devices, United Arab Emirates, Volume (Units), Forecast, 2010-2017 66
Table 36: Metered Dose Inhaler Devices, United Arab Emirates, Average Price ($), Historic, 2003-2010 67
Table 37: Metered Dose Inhaler Devices, United Arab Emirates, Average Price ($), Forecast, 2010-2017 67
Table 38: Metered Dose Inhaler Devices, United Arab Emirates, Distribution Share by Revenue ($m), 2009-2010 68
Table 39: Metered Dose Inhaler Devices, United Arab Emirates, Company Share by Revenue ($m), 2009-2010 70
Table 40: Needle Free Injections, United Arab Emirates, Revenue ($m), Historic, 2003-2010 71
Table 41: Needle Free Injections, United Arab Emirates, Revenue ($m), Forecast, 2010-2017 72
Table 42: Needle Free Injections, United Arab Emirates, Volume (Units), Historic, 2003-2010 73
Table 43: Needle Free Injections, United Arab Emirates, Volume (Units), Forecast, 2010-2017 74
Table 44: Needle Free Injections, United Arab Emirates, Average Price ($), Historic, 2003-2010 75
Table 45: Needle Free Injections, United Arab Emirates, Average Price ($), Forecast, 2010-2017 75
Table 46: Needle Free Injections, United Arab Emirates, Distribution Share by Revenue ($m), 2009-2010 76
Table 47: Needle Free Injections, United Arab Emirates, Company Share by Revenue ($m), 2009-2010 77
Table 48: USD to Local Currency, United Arab Emirates, Average Actual Rate 2003-2010 90
List of Figures
1.2 List of Figures
Figure 1: Drug Delivery Devices, United Arab Emirates, Overall Revenue ($m), 2003-2017 10
Figure 2: Drug Delivery Devices, United Arab Emirates, Overall Revenue ($m), Historic, 2003-2010 12
Figure 3: Drug Delivery Devices, United Arab Emirates, Overall Revenue ($m), Forecast, 2010-2017 14
Figure 4: Drug Delivery Devices, United Arab Emirates, Category Volume (Units), 2003-2017 16
Figure 5: Drug Delivery Devices, United Arab Emirates, Category Volume (Units), Historic, 2003-2010 17
Figure 6: Drug Delivery Devices, United Arab Emirates, Category Volume (Units), Forecast, 2010-2017 19
Figure 7: Drug Delivery Devices, United Arab Emirates, Company Share (%), 2010 21
Figure 8: Central Venous Catheters, United Arab Emirates, Revenue ($m) by Segment, Historic, 2003-2010 23
Figure 9: Central Venous Catheters, United Arab Emirates, Revenue ($m) by Segment, Forecast, 2010-2017 25
Figure 10: Central Venous Catheters, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010 27
Figure 11: Central Venous Catheters, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017 29
Figure 12: Central Venous Catheters, United Arab Emirates, Company Share (%), 2010 33
Figure 13: Infusion Systems, United Arab Emirates, Revenue ($m) by Segment, Historic, 2003-2010 35
Figure 14: Infusion Systems, United Arab Emirates, Revenue ($m) by Segment, Forecast, 2010-2017 37
Figure 15: Syringe Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Historic, 2003-2010 39
Figure 16: Syringe Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 41
Figure 17: Ambulatory Infusion Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Historic, 2003-2010 43
Figure 18: Ambulatory Infusion Pumps, United Arab Emirates, Revenue ($m) by Sub-Segment, Forecast, 2010-2017 45
Figure 19: Infusion Systems, United Arab Emirates, Volume (Units) by Segment, Historic, 2003-2010 47
Figure 20: Infusion Systems, United Arab Emirates, Volume (Units) by Segment, Forecast, 2010-2017 49
Figure 21: Syringe Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2003-2010 51
Figure 22: Syringe Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2010-2017 53
Figure 23: Ambulatory Infusion Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Historic, 2003-2010 55
Figure 24: Ambulatory Infusion Pumps, United Arab Emirates, Volume (Units) by Sub-Segment, Forecast, 2010-2017 57
Figure 25: Infusion Systems, United Arab Emirates, Company Share (%), 2010 61
Figure 26: Metered Dose Inhaler Devices, United Arab Emirates, Revenue ($m), Historic, 2003-2010 63
Figure 27: Metered Dose Inhaler Devices, United Arab Emirates, Revenue ($m), Forecast, 2010-2017 64
Figure 28: Metered Dose Inhaler Devices, United Arab Emirates, Volume (Units), Historic, 2003-2010 65
Figure 29: Metered Dose Inhaler Devices, United Arab Emirates, Volume (Units), Forecast, 2010-2017 66
Figure 30: Metered Dose Inhaler Devices, United Arab Emirates, Company Share (%), 2010 69
Figure 31: Needle Free Injections, United Arab Emirates, Revenue ($m), Historic, 2003-2010 71
Figure 32: Needle Free Injections, United Arab Emirates, Revenue ($m), Forecast, 2010-2017 72
Figure 33: Needle Free Injections, United Arab Emirates, Volume (Units), Historic, 2003-2010 73
Figure 34: Needle Free Injections, United Arab Emirates, Volume (Units), Forecast, 2010-2017 74
Figure 35: Needle Free Injections, United Arab Emirates, Company Share (%), 2010 77
Figure 36: Global Markets Direct Methodology 84
